- Home
- CMPS vs EMX Comparison
CMPS vs EMX Comparison
Compare CMPS & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- EMX
- Stock Information
- Founded
- CMPS 2020
- EMX N/A
- Country
- CMPS United Kingdom
- EMX Canada
- Employees
- CMPS N/A
- EMX N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- EMX
- Sector
- CMPS Health Care
- EMX
- Exchange
- CMPS Nasdaq
- EMX Nasdaq
- Market Cap
- CMPS 364.9M
- EMX 338.0M
- IPO Year
- CMPS 2020
- EMX N/A
- Fundamental
- Price
- CMPS $4.61
- EMX $3.32
- Analyst Decision
- CMPS Strong Buy
- EMX Strong Buy
- Analyst Count
- CMPS 7
- EMX 2
- Target Price
- CMPS $17.00
- EMX $5.38
- AVG Volume (30 Days)
- CMPS 1.8M
- EMX 377.5K
- Earning Date
- CMPS 07-31-2025
- EMX 08-11-2025
- Dividend Yield
- CMPS N/A
- EMX N/A
- EPS Growth
- CMPS N/A
- EMX N/A
- EPS
- CMPS N/A
- EMX 0.04
- Revenue
- CMPS N/A
- EMX $29,864,000.00
- Revenue This Year
- CMPS N/A
- EMX $11.08
- Revenue Next Year
- CMPS N/A
- EMX $3.72
- P/E Ratio
- CMPS N/A
- EMX $69.73
- Revenue Growth
- CMPS N/A
- EMX N/A
- 52 Week Low
- CMPS $2.25
- EMX $1.59
- 52 Week High
- CMPS $8.54
- EMX $3.39
- Technical
- Relative Strength Index (RSI)
- CMPS 60.45
- EMX 63.35
- Support Level
- CMPS $3.97
- EMX $3.04
- Resistance Level
- CMPS $4.42
- EMX $3.37
- Average True Range (ATR)
- CMPS 0.22
- EMX 0.12
- MACD
- CMPS -0.01
- EMX -0.01
- Stochastic Oscillator
- CMPS 91.43
- EMX 82.95
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.